Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | WU-CART-007 |
| Trade Name | |
| Synonyms | WU-CART 007|WU-CART007 |
| Drug Descriptions |
WU-CART-007 are allogeneic T-lymphocytes that have been engineered to express a chimeric antigen receptor (CAR) that targets CD7, potentially resulting in killing of tumor cells expressing CD7 and inhibition of tumor growth (Blood (2021) 138 (Supplement 1): 2772). |
| DrugClasses | CD7 Immune Cell Therapy 4 |
| CAS Registry Number | NA |
| NCIT ID | C182072 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| WU-CART-007 | WU-CART-007 | 0 | 3 |